propofol has been researched along with Gastric Diseases in 2 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the dosage of remifentanil used in endoscopy is unclear." | 2.87 | Effects of small-dose remifentanil combined with index of consciousness monitoring on gastroscopic polypectomy: a prospective, randomized, single-blinded trial. ( He, R; Li, F; Li, Z; Liu, M; Wang, S; Wu, H; Yang, D, 2018) |
| "Propofol can inhibit HMGB1 expression and TLR4/MyD88/NF-κB-mediated inflammatory responses, and hamper apoptosis, which may contribute to its protective action against ethanol-induced gastric mucosal injury." | 1.39 | Propofol participates in gastric mucosal protection through inhibiting the toll-like receptor-4/nuclear factor kappa-B signaling pathway. ( Fei, SJ; Liu, HX; Wu, KJ; Ye, HH; Zhang, JL; Zhang, XW; Zhang, YM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M | 1 |
| Wu, H | 1 |
| Yang, D | 1 |
| Li, F | 1 |
| Li, Z | 1 |
| Wang, S | 1 |
| He, R | 1 |
| Ye, HH | 1 |
| Wu, KJ | 1 |
| Fei, SJ | 1 |
| Zhang, XW | 1 |
| Liu, HX | 1 |
| Zhang, JL | 1 |
| Zhang, YM | 1 |
1 trial available for propofol and Gastric Diseases
| Article | Year |
|---|---|
Effects of small-dose remifentanil combined with index of consciousness monitoring on gastroscopic polypectomy: a prospective, randomized, single-blinded trial.
Topics: Adult; Analgesics, Opioid; Anesthetics, Intravenous; China; Conscious Sedation; Consciousness; Femal | 2018 |
1 other study available for propofol and Gastric Diseases
| Article | Year |
|---|---|
Propofol participates in gastric mucosal protection through inhibiting the toll-like receptor-4/nuclear factor kappa-B signaling pathway.
Topics: Animals; Ethanol; Gastric Mucosa; Hypnotics and Sedatives; Male; Mice; Mice, Inbred C57BL; NF-kappa | 2013 |